Correlation Between HCW Biologics and Cardiol Therapeutics
Can any of the company-specific risk be diversified away by investing in both HCW Biologics and Cardiol Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HCW Biologics and Cardiol Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HCW Biologics and Cardiol Therapeutics Class, you can compare the effects of market volatilities on HCW Biologics and Cardiol Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HCW Biologics with a short position of Cardiol Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of HCW Biologics and Cardiol Therapeutics.
Diversification Opportunities for HCW Biologics and Cardiol Therapeutics
-0.16 | Correlation Coefficient |
Good diversification
The 3 months correlation between HCW and Cardiol is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding HCW Biologics and Cardiol Therapeutics Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardiol Therapeutics and HCW Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HCW Biologics are associated (or correlated) with Cardiol Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardiol Therapeutics has no effect on the direction of HCW Biologics i.e., HCW Biologics and Cardiol Therapeutics go up and down completely randomly.
Pair Corralation between HCW Biologics and Cardiol Therapeutics
Given the investment horizon of 90 days HCW Biologics is expected to generate 20.42 times more return on investment than Cardiol Therapeutics. However, HCW Biologics is 20.42 times more volatile than Cardiol Therapeutics Class. It trades about 0.13 of its potential returns per unit of risk. Cardiol Therapeutics Class is currently generating about -0.12 per unit of risk. If you would invest 43.00 in HCW Biologics on September 1, 2024 and sell it today you would earn a total of 4.00 from holding HCW Biologics or generate 9.3% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
HCW Biologics vs. Cardiol Therapeutics Class
Performance |
| Timeline |
| HCW Biologics |
| Cardiol Therapeutics |
HCW Biologics and Cardiol Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with HCW Biologics and Cardiol Therapeutics
The main advantage of trading using opposite HCW Biologics and Cardiol Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HCW Biologics position performs unexpectedly, Cardiol Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardiol Therapeutics will offset losses from the drop in Cardiol Therapeutics' long position.| HCW Biologics vs. Anebulo Pharmaceuticals | HCW Biologics vs. Rezolute | HCW Biologics vs. Eliem Therapeutics | HCW Biologics vs. Molecular Partners AG |
| Cardiol Therapeutics vs. Flora Growth Corp | Cardiol Therapeutics vs. ABVC Biopharma | Cardiol Therapeutics vs. Indaptus Therapeutics | Cardiol Therapeutics vs. HCW Biologics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |